The Lancet Microbe

The Lancet Microbe is an #OpenAccess journal publishing innovative and practice-changing research and opinion in clinical #microbiology

[The Lancet Microbe @LancetMicrobe]

The Lancet Microbe is leaving this platform but joining another ⤵️

You can now find us on
Bluesky 👉 https://t.co/NWO58AfFJx

🌐 And, of course, online at https://t.co/txqFEYfsha. Follow us!

[The Lancet Microbe @LancetMicrobe]

New research article

Interactions between live attenuated #influenza vaccine and nasopharyngeal #microbiota among children aged 24–59 months in The Gambia: a phase 4, open-label, randomised controlled trial

https://t.co/ZzE1Dxp96u

#OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New research article

Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study

https://t.co/A2nU93UxdT

#Mpox #OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New research article

Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study

https://t.co/yLohSgj68d

#AMR #OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New review article

Clinical implications of maternal multikingdom transmissions and early-life microbiota

https://t.co/nf0Kv4fhyo

#OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

Our January issue is now online:

https://t.co/I1d8H6v9df

The journal is #OpenAccess, so you are free to explore all the content. But these hashtags offer a flavour: #AMR #Candida #Mycobacterium #tuberculosis #TB #HPV #enterovirus #EVD68

#OA

[The Lancet Microbe @LancetMicrobe]

New research article

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02)

https://t.co/FAyQuBGqIT

#tuberculosis #TB #OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New research article

Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of #Mycobacterium #tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data

https://t.co/UIjoz2qnQp

#TB #OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New research article

Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for #Helicobacter pylori

https://t.co/vpWHt4UfDF

#AMR #OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New research article

Immune responses to #SARSCoV2 in sub-Saharan Africa and western Europe: a retrospective, population-based, cross-sectional study

https://t.co/eXF4ocM98X

#OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New research article

Evaluation of a point-of-care immunochromatographic assay for #EntericFever in Dhaka, Bangladesh: a prospective diagnostic accuracy study

https://t.co/VNKl0Dq7O4

#Salmonella #typhoid #OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New research article

Artemether–lumefantrine–amodiaquine or artesunate–amodiaquine combined with single low-dose primaquine to reduce #Plasmodium falciparum #malaria transmission in Ouélessébougou, Mali

https://t.co/Qnk7Pu8zs6

#OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New review article

Sensors for surveillance of RNA viruses: a One Health perspective

https://t.co/yA9M68Ksx9

#OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New review article

Duration of viral persistence in human semen after acute viral infection: a systematic review

https://t.co/KW1p0TBWFI

#OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

Our December issue is now online:

https://t.co/I1d8H6v9df

The journal is #OpenAccess, so you are free to explore all the content. But these hashtags offer a flavour: #AMR #schistosomiasis #pneumococcus #endocarditis #Mycobacterium #influenza #YellowFever #malaria

[The Lancet Microbe @LancetMicrobe]

New research article

Molecular features of the serological IgG repertoire elicited by egg-based, cell-based, or recombinant haemagglutinin-based seasonal #influenza vaccines

https://t.co/EFGKaTcI5s

#OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New 2-paper series: Tattoo-Associated Microbial Infections

Paper 2: Causes, patterns, and epidemiology of tattoo-associated infections since 1820

https://t.co/UWojozDrKI

#IDSky #ClinMicro #OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New 2-paper series: Tattoo-Associated Microbial Infections

Paper 1: Microbiology of tattoo-associated infections since 1820

https://t.co/0CtSKWKurf

#IDSky #ClinMicro #OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New research article

Bacteriology testing and antimicrobial resistance detection capacity of national tiered laboratory networks in sub-Saharan Africa: an analysis from 14 countries

https://t.co/1l35fxuDTl

#AMR #OpenAccess #OA

[The Lancet Microbe @LancetMicrobe]

New research article

The spread of molecular markers of #artemisinin partial resistance and diagnostic evasion in Eritrea: a retrospective molecular epidemiology study

https://t.co/eNeTJ3RlPO

#malaria #AMR #OpenAccess #OA